D
Delbert G. Robinson
Researcher at The Feinstein Institute for Medical Research
Publications - 87
Citations - 6347
Delbert G. Robinson is an academic researcher from The Feinstein Institute for Medical Research. The author has contributed to research in topics: Schizophrenia & Psychosis. The author has an hindex of 33, co-authored 87 publications receiving 5366 citations. Previous affiliations of Delbert G. Robinson include University of Mississippi & Yeshiva University.
Papers
More filters
Journal ArticleDOI
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
Alan S. Bellack,Charles L. Bowden,Christopher R. Bowie,Matthew J. Byerly,William T. Carpenter,Laurel A. Copeland,Albana M Dassori,John M. Davis,Colin A. Depp,Esperanza Diaz,Lisa B. Dixon,John P. Docherty,Eric B. Elbogen,S. Nasser Ghaemi,Paul E. Keck,Samuel J. Keith,Martijn J. Kikkert,John Lauriello,Barry D. Lebotz,Stephen R. Marder,Joseph P. McEvoy,David J. Miklowitz,Alexander L. Miller,Paul A. Nakonezny,Henry A. Nasrallah,Michael W. Otto,Roy H. Perlis,Delbert G. Robinson,Gary S. Sachs,Martha Sajatovic,Nina R. Schooler,S. Charles Schulz,Jan Scoff,Jair C. Soares,Stephen M. Strakowski,Holly A. Swartz,Marcia Valenstein,Dawn I. Velligan,Peter J. Weiden,Emily M. Woltmann,John E. Zeber +40 more
TL;DR: Recommendations for addressing adherence problems to improve patient outcomes are developed, noting that multiple problems may be involved, requiring a combination of interventions.
Journal ArticleDOI
Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program
John M. Kane,Delbert G. Robinson,Nina R. Schooler,Kim T. Mueser,David L. Penn,Robert A. Rosenheck,Jean Addington,Mary F. Brunette,Christoph U. Correll,Sue E. Estroff,Patricia Marcy,James Robinson,Piper Meyer-Kalos,Jennifer D. Gottlieb,Shirley M. Glynn,David W. Lynde,Ronny Pipes,Benji T. Kurian,Alexander L. Miller,Susan T. Azrin,Amy B. Goldstein,Joanne B. Severe,Haiqun Lin,Kyaw Sint,Majnu John,Robert K. Heinssen +25 more
TL;DR: Comprehensive care for first-episode psychosis can be implemented in U.S. community clinics and improves functional and clinical outcomes, and effects are more pronounced for those with shorter duration of untreated psychosis.
Journal ArticleDOI
Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression
Christoph U. Correll,Britta Galling,Britta Galling,Aditya Pawar,Anastasia Krivko,Chiara Bonetto,Mirella Ruggeri,Thomas J. Craig,Merete Nordentoft,Merete Nordentoft,Vinod H. Srihari,Sinan Guloksuz,Sinan Guloksuz,Christy L.M. Hui,Eric Y.H. Chen,Marcelo Valencia,Francisco Juárez,Delbert G. Robinson,Delbert G. Robinson,Nina R. Schooler,Mary F. Brunette,Kim T. Mueser,Robert A. Rosenheck,Patricia Marcy,Jean Addington,Sue E. Estroff,James Robinson,David L. Penn,Joanne B. Severe,John M. Kane,John M. Kane +30 more
TL;DR: In this paper, the authors compared early intervention services (EIS) with treatment as usual (TAU) for early-phase psychosis and found that EIS was associated with better outcomes than TAU at the end of treatment for all 13 meta-analyzable outcomes.
Journal ArticleDOI
Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
Terry E. Goldberg,Robert Goldman,Katherine E. Burdick,Anil K. Malhotra,Todd Lencz,Raman C. Patel,Woerner M,Nina R. Schooler,John M. Kane,Delbert G. Robinson +9 more
TL;DR: The cognitive improvements observed in the trial were consistent in magnitude with practice effects observed in healthy controls, suggesting that some of the improvements in cognition in the first-episode schizophrenia group may have been due to practice effects (ie, exposure, familiarity, and/or procedural learning).
Journal ArticleDOI
Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation.
Philip R. Szeszko,Philip R. Szeszko,Robert H. Lipsky,Claudia Mentschel,Delbert G. Robinson,Delbert G. Robinson,Handan Gunduz-Bruce,Serge Sevy,Serge Sevy,Manzar Ashtari,Barbara Napolitano,Robert M. Bilder,John M. Kane,John M. Kane,David Goldman,Anil K. Malhotra,Anil K. Malhotra +16 more
TL;DR: The findings implicate genetic involvement of BDNF in variation of human hippocampal volume and suggest that this effect may be greater among patients compared to healthy volunteers.